Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Rees

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
The Journal of Biological Chemistry|March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivoAdam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
International Journal of Cancer|February 22, 2005
Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSFMurrium Ahmad, Robert C Rees, Stephanie E McArdle, et al.
The Prostate|February 4, 2009
Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissueThomas J Walton, Geng Li, Thomas A McCulloch, et al.
Cancer Immunity|January 12, 2010
HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancersMorgan G Mathieu, Adam J Linley, Stephen P Reeder, et al.
The Prostate|May 15, 2003
Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapyRichard J Parkinson, Shahid Mian, Michael C Bishop, et al.
Scientific Reports|January 18, 2017
A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristicsNaomi Harner-Foreman, Jayakumar Vadakekolathu, Stéphanie A Laversin, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53José Manuel Rojas, Stephanie E B McArdle, Roger B V Horton, et al.
Analytical Biochemistry|June 23, 2009
Estimation of peptide concentration by a modified bicinchoninic acid assayKrishan N Kapoor, Danielle T Barry, Robert C Rees, et al.
International Journal of Cancer|April 8, 2004
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2Judith M Ramage, Rachael Metheringham, Andrew Conn, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.
The Journal of Biological Chemistry|March 7, 2012
The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivoAdam J Linley, Morgan G Mathieu, Amanda K Miles, et al.
International Journal of Cancer|February 22, 2005
Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSFMurrium Ahmad, Robert C Rees, Stephanie E McArdle, et al.
The Prostate|February 4, 2009
Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissueThomas J Walton, Geng Li, Thomas A McCulloch, et al.
Cancer Immunity|January 12, 2010
HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancersMorgan G Mathieu, Adam J Linley, Stephen P Reeder, et al.
The Prostate|May 15, 2003
Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapyRichard J Parkinson, Shahid Mian, Michael C Bishop, et al.
Scientific Reports|January 18, 2017
A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristicsNaomi Harner-Foreman, Jayakumar Vadakekolathu, Stéphanie A Laversin, et al.
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53José Manuel Rojas, Stephanie E B McArdle, Roger B V Horton, et al.
Analytical Biochemistry|June 23, 2009
Estimation of peptide concentration by a modified bicinchoninic acid assayKrishan N Kapoor, Danielle T Barry, Robert C Rees, et al.
International Journal of Cancer|April 8, 2004
Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific to the endothelial antigen Tie-2Judith M Ramage, Rachael Metheringham, Andrew Conn, et al.
Pageof 6